指南与共识外周动脉疾病

TASC II D级股腘动脉病变腔内治疗在严重肢体缺血患者中的结局

Endovascular treatment of TransAtlantic Inter-Society Consensus II D femoropopliteal lesions in patients with critical limb ischemia.
指南 / 共识 · J Vasc Surg · 2019-01-02

该研究回顾性分析了91例因TASC II D级股腘动脉病变接受腔内治疗的严重肢体缺血患者,技术失败率3.3%,3年一期通畅率50.6%,4年保肢率63.7%;腘动脉闭塞累及三分叉者的60天一期通畅率优于长度>20 cm的股浅动脉闭塞者,女性与不良生存相关,腘动脉组支架使用与肢体丢失率高相关。

要点

  • TASC II D级股腘动脉病变腔内治疗技术失败率3.3%,3年一期通畅率50.6%。

核心结论

  • 对TASC II D级股腘动脉病变行腔内治疗,腘动脉闭塞累及三分叉者的60天一期通畅率优于股浅动脉闭塞长度>20 cm者。
  • 女性性别与不良生存相关,腘动脉闭塞患者使用支架与高肢体丢失率相关。

研究设计与样本

  • 回顾性分析2011年1月至2016年12月共91例手术,均针对TASC II D级股腘动脉病变。
  • 70例为腘动脉闭塞累及三分叉血管,12例为股浅动脉闭塞长度>20 cm,9例同时符合两者。

主要发现

  • technical failure observed in 3 patients (3.3%).
  • Primary patency at 30 days, 1 year, 2 years, and 3 years was 91%, 60.1%, 55.7%, and 50.6%, respectively.
  • Limb salvage at 30 days, 1 year, 2 years, 3 years, and 4 years was 95.2%, 82.2%, 76.9%, 71.8%, and 63.7%, respectively.
  • Reinterventions were necessary in 11.1% of the patients.
  • Comparison of curves revealed significant differences in the 60-day primary patency for the SFA and popliteal groups (standard error, <10%; log-rank, P = .039).

关键数值与推荐

  • 约44.4%的患者为男性,平均年龄67.3 ± 20.7岁。
  • 高血压、糖尿病、当前吸烟、肾功能损害、冠心病和心功能不全分别占92.3%、66.6%、21.7%、7.6%、25.6%和62.8%。
  • 所有患者均有严重肢体缺血,Rutherford 4、5、6级分别占11.5%、84.6%和3.8%。
  • 平均每患者使用支架数为0.7 ± 0.65。

临床怎么用

  • 对于TASC II D级股腘动脉病变,腔内治疗可作为严重肢体缺血患者的一种选择,尤其腘动脉闭塞累及三分叉者。
  • 女性患者需关注生存风险,腘动脉闭塞患者使用支架需权衡肢体丢失风险。

局限性

  • 回顾性研究,样本量有限(91例手术),可能存在选择偏倚。
  • 随访时间和部分亚组样本量未报告,限制结论外推。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The outcomes of endovascular treatment of femoropopliteal atherosclerotic lesions have been improving recently. Although open repair is indicated for class D femoropopliteal lesions based on the TransAtlantic Inter-Society Consensus II (TASC II) document, in some cases, it is reasonable to use the endovascular approach for these lesions. The aim of this study was to retrospectively analyze the technical aspects and outcomes of treating TASC II D femoropopliteal disease with endovascular approaches. METHODS: In total, 91 procedures between January 2011 and December 2016 were retrospectively analyzed. We collected data corresponding to the technical aspects and outcomes of treatment from an electronic database. Images and videos of all procedures were reviewed. Among the 91 procedures, 70 were for popliteal artery occlusions involving the trifurcation vessels, and 12 were for superficial femoral artery (SFA) occlusions of >20 cm in length; 9 procedures for occlusions meeting both criteria were also performed. The χ2 test was employed for statistical analyses, and logistic regression analyses were conducted to identify risk factors. Patency, wound healing, and survival were analyzed using the Kaplan-Meier method. Statistical significance was considered at P < .05. RESULTS: Approximately 44.4% of all patients were male. The mean age was 67.3 ± 20.7 years. Hypertension, diabetes, current smoker, kidney impairment, coronary disease, and cardiac insufficiency were identified in 92.3%, 66.6%, 21.7%, 7.6%, 25.6%, and 62.8% of the patients, respectively. All included patients had critical limb ischemia (11.5%, 84.6%, and 3.8% of cases corresponding to Rutherford categories 4, 5, and 6, respectively). Technical failure was observed in three patients (3.3%). The mean number of stents used was 0.7 ± 0.65 per patient. Primary patency at 30 days, 1 year, 2 years, and 3 years was 91%, 60.1%, 55.7%, and 50.6%, respectively. Limb salvage at 30 days, 1 year, 2 years, 3 years, and 4 years was 95.2%, 82.2%, 76.9%, 71.8%, and 63.7%, respectively. Reinterventions were necessary in 11.1% of the patients. Comparison of curves revealed significant differences in the 60-day primary patency for the SFA and popliteal groups (standard error, <10%; log-rank, P = .039). Analysis of the risk and technical factors affecting primary patency, limb salvage, and overall survival indicated that female sex was associated with poor survival (odds ratio, 8.942; 95% confidence interval, 1.105-72.36) and that the use of stents was associated with high rates of limb loss in the popliteal group (log-rank, P = .033). CONCLUSIONS: For endovascular treatment of TASC II D femoropopliteal lesions, primary patency was better in patients with popliteal artery occlusions involving the trifurcation vessels than in those with SFA occlusions >20 cm in length. Female sex was associated with the risk of major amputations, and the use of stents in patients with popliteal occlusions was associated with major limb loss.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Biagioni RB, Brandão GD, Biagioni LC, et al. Endovascular treatment of TransAtlantic Inter-Society Consensus II D femoropopliteal lesions in patients with critical limb ischemia. J Vasc Surg. 2019. PMID: 30611581. doi:10.1016/j.jvs.2018.08.176

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。